Friday, 30 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Annual Report

Bacil Pharma Annual Report

Bacil Pharma Limited submitted its 39th Annual Report for FY 2025-26. The Annual General Meeting is scheduled for September 23, 2026, via video conferencing.

Source

BSE filing, NSE: BACPHAR. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Bacil Pharma Ltd: key numbers

Share price
₹18.40
Market cap
₹26.41 Cr
Revenue (annual)
₹0.00 Cr
Net profit (annual)
₹1.56 Cr
P/E (TTM)
41.8×Sector 48.7×
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Bacil Pharma Ltd

All →

Other annual report announcements

All →